Barry Dvorchik
Impact in
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
- Metabolism and Genetic Disorders
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Epigenetics and DNA Methylation 3
-
- Metabolism and Genetic Disorders 8
- Co-authors
- Elliot S. Vesell (11 shared papers)Robert D. Arbeit (2 shared papers)D J Brazier (1 shared paper)E.S. Vesell (3 shared papers)G. Thomas Passananti (4 shared papers)Edward R. Garrett (1 shared paper)Gabriel A. Kyerematen (2 shared papers)Helen Kastrissios (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (8 papers)The Journal of Clinical Pharmacology (7 papers)Drug Metabolism and Disposition (5 papers)Antimicrobial Agents and Chemotherapy (3 papers)Pharmacology (2 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Barry Dvorchik
44 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 122
- Clinical Biochemistry 230
- Pharmacology 233
- Pharmacology 408
- Infectious Diseases 415
- Molecular Medicine 90
Countries citing papers authored by Barry Dvorchik
This map shows the geographic impact of Barry Dvorchik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Dvorchik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Dvorchik more than expected).
Fields of papers citing papers by Barry Dvorchik
This network shows the impact of papers produced by Barry Dvorchik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Dvorchik. The network helps show where Barry Dvorchik may publish in the future.
Co-authors
The 25 scholars most cited alongside Barry Dvorchik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 303 | |
| 2 | 2004 | 129 | |
| 3 | 1975 | 101 | |
| 4 | 1982 | 101 | |
| 5 | 2004 | 85 | |
| 6 | 2002 | 78 | |
| 7 | 1976 | 68 | |
| 8 | 1969 | 66 | |
| 9 | 1979 | 62 | |
| 10 | A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors. | 2000 | 52 |
| 11 | 1978 | 44 | |
| 12 | 1981 | 44 | |
| 13 | 1983 | 43 | |
| 14 | 2004 | 40 | |
| 15 | 1980 | 37 | |
| 16 | 1978 | 35 | |
| 17 | 1999 | 35 | |
| 18 | 1985 | 29 | |
| 19 | 2004 | 26 | |
| 20 | 2008 | 21 |
About Barry Dvorchik
Barry Dvorchik is a scholar working on Molecular Biology, Clinical Biochemistry, Pharmacology, Pharmacology and Oncology, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Pharmacogenetics and Drug Metabolism (9 papers), Metabolism and Genetic Disorders (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Analytical Methods in Pharmaceuticals (4 papers), Diet and metabolism studies (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Clinical Biochemistry (230 citations), Pharmacology (233 citations), Pharmacology (408 citations), Infectious Diseases (415 citations) and Molecular Medicine (90 citations). Barry Dvorchik has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Elliot S. Vesell, Robert D. Arbeit, D J Brazier, E.S. Vesell, G. Thomas Passananti, Edward R. Garrett, Gabriel A. Kyerematen, Helen Kastrissios, William Knebel and Julia Chung. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, Drug Metabolism and Disposition, Antimicrobial Agents and Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.